Graduate Medical Education
Research Journal
Volume 2

Issue 1

Article 34

September 2020

Thiamine Supplementation Does Not Improve Outcomes in
Hospitalized Patients with Encephalopathy
Daniel J. Zhou
University of Nebraska Medical Center

Navya Joseph
University of Nebraska Medical Center

Kaeli Samson
University of Nebraska Medical Center

Matthew Purbaugh
University of Nebraska Medical Center

Brian Villafuerte-Trisolini
University of Nebraska Medical Center

See next page for additional authors

Follow this and additional works at: https://digitalcommons.unmc.edu/gmerj
Part of the Higher Education Commons, and the Medicine and Health Sciences Commons

Recommended Citation
Zhou, D. J., Joseph, N., Samson, K., Purbaugh, M., Villafuerte-Trisolini, B., Kodali, N., , Kedar, S. Thiamine
Supplementation Does Not Improve Outcomes in Hospitalized Patients with Encephalopathy. Graduate
Medical Education Research Journal. 2020 Sep 29; 2(1).
https://digitalcommons.unmc.edu/gmerj/vol2/iss1/34

This Conference Proceeding is brought to you for free and open access by DigitalCommons@UNMC. It has been
accepted for inclusion in Graduate Medical Education Research Journal by an authorized editor of
DigitalCommons@UNMC. For more information, please contact digitalcommons@unmc.edu.

Thiamine Supplementation Does Not Improve Outcomes in Hospitalized Patients
with Encephalopathy
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0
License.

Authors
Daniel J. Zhou, Navya Joseph, Kaeli Samson, Matthew Purbaugh, Brian Villafuerte-Trisolini, Neeharica
Kodali, and Sachin Kedar

This conference proceeding is available in Graduate Medical Education Research Journal:
https://digitalcommons.unmc.edu/gmerj/vol2/iss1/34

*Names in bold type indicate presenting author.

behavior and failure patterns in H&N may
be different from trunk/extremity, supporting
consideration of dedicated H&N trial. 
https://doi.org/10.32873/unmc.dc.gmerj.2.1.032

Table 1.
+SLN group demonstrates higher rate of local (LR), nodal (LNR), and systemic (SR) recurrence, as
well as higher rate of death due to disease (DOD) when compared with -SLN group. Within +SLN
group, patients who underwent complete lymph node dissection (CLND) surprisingly have higher rate
of LR, LNR, SR, and DOD.
Completed SLNBx
(N= 108)

LR %

LNR %

Local/Regional
recurrence %

SR %

Combined
Sys/Nodal %

DOD %

NED %

SLN –ve (77)

18%

8%

21%

13%

1%

7%

93%

SLN +ve (31)
CLND (20)
+SLNBx only (11)
p-value

23%

0%
0.03*

32%

9%


35%

9%
0.02*

45%
55%
27%
0.26

29%
40%
9%
0.15

29%
35%
18%
0.43

55%
45%
73%
0.26
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Table 1.
Demographic and clinical characteristics of hospitalized patients with encephalopathy.
Thiamine Group


Type: Original Research
Background: In hospitalized and
        
         
and increases risk for encephalopathy.1,2
Thiamine supplementation for patients with
encephalopathy has become routine at UNMC
           
hypothesized that thiamine supplementation
in hospitalized patients with encephalopathy
would decrease their length of stay (LOS).
Methods: Adults (age >19 years) with index
admission to UNMC between 1/1/2017 and
12/31/2017, hospital stay of 3-30 days, and
ICD-10 code associated with encephalopathy
           
health record data access core. Primary
outcome was hospital LOS, which we logtransformed due to skewness. Model adjusted
mean log LOS estimates were exponentiated
to obtain geometric means. Patients in
the Thiamine group received at least one
dose of supplemental thiamine (including
multivitamins). A general linear model was
used to evaluate the association between log
LOS and thiamine supplementation.
Results:        
met the above criteria. Table 1 describes
the cohort demographics and clinical
characteristics. After adjusting for potential
confounding variables (denoted in Table 1),
the mean log LOS was 1.95 for the Thiamine
group and 1.63 for the No Thiamine group (p
<0.0001).

Sept. 2020 | Vol. 2 | Issue 1

Demographic Information
Age (mean ± SD)*
Gender*
Female
Male
Race
Black
White
Other
Ethnicity
Hispanic
Not Hispanic
Work status
Disabled
Employed/Student/Retired
Not employed
Insurance status*
Insured
Not insured
Clinical Characteristics
Log (DRG weight) (mean ± SD)
Alcohol use*
PMH of malabsorption
PMH of GI disease
PMH of malnutrition*
PMH of cancer
PMH of GI surgery
Home use of loop diuretics
Home use of PPIs
Sepsis during hospital stay*
DKA during hospital stay*
Neurology service consulted*
Outcomes
Log (Length of stay) (mean ± SD)

  
No Thiamine Group


P-value

66.5 ± 18.1

59.4 ± 15.5

<0.0001a
0.0004

67 (37.6)
111 (62.4)

423 (52.4)
384 (47.6)

32 (18.4)
129 (74.1)
13 (7.5)

119 (14.8)
627 (78.1)
57 (7.1)

8 (4.5)
170 (95.5)

43 (5.3)
763 (94.7)

44 (25.1)
81 (46.3)
50 (28.6)

166 (20.7)
524 (65.3)
112 (14.0)

151 (84.8)
27 (15.2)

741 (91.8)
66 (8.2)

0.43 ± 0.64
68 (51.9)
20 (11.2)
22 (12.4)
46 (25.8)
40 (22.5)
28 (15.7)
4 (2.2)
1 (0.6)
46 (25.8)
27 (15.2)
57 (32.0)

0.26 ± 0.53
166 (26.0)
115 (14.3)
113 (14.0)
167 (20.7)
220 (27.3)
98 (12.1)
17 (2.1)
17 (2.1)
193 (23.9)
72 (8.9)
141 (17.5)

0.001a
<0.0001
0.29
0.56
0.13
0.19
0.19
0.78b
0.22b
0.59
0.01
<0.0001

1.60 ± 0.60

<0.0001a

0.47

0.65

<0.0001

0.004

1.98 ± 0.70

Abbreviations: SD = standard deviation. DRG =
diagnosis-related group. PMH = past medical history.
GI = gastrointestinal. DKA = diabetic ketoacidosis. LOS
= length of stay.
P-values from Chi-Square tests, unless otherwise

a P-values from t-test.

b P-values from Fisher’s exact test.
* Potential confounding variables that can contribute to
log (LOS) via linear model.
Demographic information, clinical characteristics,
and primary outcome were compared between the
Thiamine group and No Thiamine group.
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Conclusion: Contrary to prevailing
expectations and our study hypothesis, we
found that thiamine supplementation in
hospitalized patients with encephalopathy
did not improve LOS. Our results are
           
of supplemental thiamine in other disease
conditions such as sepsis (VITAMINS study)
and congestive heart failure.3-5 We do not
recommend routine thiamine supplementation
in hospitalized patients. 
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Introduction: There are few cases of nondiverticulitis episodes of colonic perforation
following kidney transplantation throughout
literature. In the systematic literature review
by de’Angelis et al, emergency abdominal
surgery following solid organ transplantation
for non-diverticulitis causes gastrointestinal
perforation accounts of 9.2% of cases, and
about 58% of those perforations occurred
in the colon. The aim of this case series is
to review the events surrounding our two

cases of colonic perforation following renal
transplantation in hopes to gain understanding
of this rare occurrence. Consent was obtained
from the patients.

takedown and primary colonic re-anastomosis
about one year after his kidney transplant.
The second patient is currently scheduled for
future colostomy reversal.

Case: Since 2011, there have been two
events of transverse colonic perforation in the
acute post-operative period following renal
transplantation occurring at this institution.
Large volume intraperitoneal air observed
           
symptoms prompted urgent surgical
intervention in both cases. Both patients
underwent urgent exploratory laparotomy
and Hartmann procedure with resection of
perforated transverse colon and proximal
  *          

Conclusion: Various theories of nondiverticular causes of colonic perforations
are described in literature including
cytomegalovirus enterocolitis, uremic
enterocolitis, fecal impaction, and
corticosteroid administration among others.
Despite the lack of clear cause of perforation,
it is imperative to have a high index of
suspicion for these immunocompromised
patients for prompt surgical treatment. 
https://doi.org/10.32873/unmc.dc.gmerj.2.1.034
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Background: Adequate control of bleeding
during spine surgery is paramount to the
         
Tranexamic acid (TXA) is a systemic
          
blood loss during various orthopaedic
procedures. TXA’s role in posterior cervical
spinal surgery, however, remains poorly
described. Therefore we sought to evaluate
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whether prophylactic TXA administration
prior to posterior cervical fusion reduces
perioperative blood loss and mean operative
time.
Methods: Patients undergoing three to
six-level posterior cervical fusions were
retrospectively enrolled into two groups. In
the study group, 21 patients received TXA
prior to surgery, and in the control group,
21 patients did not. Patient’s younger than
19 years old, and those undergoing surgery
for infection or tumors were excluded.
Intraoperative blood loss, operative time, and
postoperative drain output were measured in
addition to demographic data.

Results: No difference existed between
groups in regards to demographics. The
study group had a lower mean operative
time (94 min) vs the control group (110
 +       
(p=0.06071). Postoperative day 1 drain output
         
(p<0.0239). Intraoperative blood loss, day
2, 3 and total drain output were lower in the
        
There were two postoperative hematomas
in the control group. No postoperative
thromboembolic events occurred in either
group.
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